Selskabets formål er at eje aktier, produktudvikling, produktion, indkøb, salg, levering, markedsføring, handel og investering samt anden hermed forbunden virksomhed efter bestyrelsens skøn.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 2.9 mia. | 190 mio. | 1.3 mia. | 571.6 mio. | 131 | |
CVR: 10114241
Secondary names: MEKU A/S, MEKU-PETCARE A/S, MEDICINKEMI ULDUM A/S
Previous names: MEDICINKEMI ULDUM A/S, MEKU A/S, LEO ANIMAL HEALTH A/S
2 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Companies in the same industry and area
Ian Machan Mackellar joined the board
Milton McCann left the board
Ian Machan Mackellar joined as director
Milton McCann left as director
KPMG P/S appointed as auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB resigned as auditor
The financial health of DECHRA VETERINARY PRODUCTS A/S appears strong, with a consistent upward trajectory in revenue and profit over the past five years. Revenue increased from 2.13 billion DKK in 2021 to 2.88 billion DKK in 2025, while profit rose from 98 million DKK to nearly 190 million DKK in the same period, indicating effective management and growing market demand. However, equity has seen a decline from 688.9 million DKK in 2023 to 571.6 million DKK in 2025, which may raise concerns about financial stability. Overall, the company is well-positioned within the pharmaceutical and healthcare supply industry, benefiting from a solid revenue base and improving profitability margins.
AI-generated summary
companydata.dk